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Abstract
Electroencephalographic measures of information processing encompass both mid-latency evoked
potentials like the pre-attentive auditory P50 potential and a host of later more cognitive
components like P300 and N400.
Difference waves have mostly been employed in studies of later event related potentials but here
this method along with low frequency filtering is applied exploratory on auditory P50 gating data,
previously analyzed in the standard format (reported in Am J Psychiatry 2003, 160:2236-8). The
exploration was motivated by the observation during visual peak detection that the AEP waveform
was different in the patient group, although this was not reflected by the peak measures. The
sample included un-medicated schizophrenia spectrum patients (n = 17) and healthy controls (n =
24). The patients had an attenuated difference P50. This attenuation was primarily seen in the sub-
sample of patients with severe negative symptoms. The difference attenuation was due to low
amplitude at the first stimulus. This suggests an abnormality in readiness more than an abnormality
in gating in the patient group.
Introduction
The deficiency in auditory P50 gating reported in numer-
ous studies of schizophrenic patients has been one of the
experimental findings that have supported the theory of
defect sensory gating in schizophrenia [1]. P50 gating is
the relative amplitude reduction of auditory evoked
potential (AEP) P50 from the first stimulus (S1) to the sec-
ond stimulus (S2). P50 is the second positive component
of the mid-latency AEP; a scalp electroencephalographic
measure of the brain response to auditory stimulation.
The P50 paradigm consists of two identical clicks pre-
sented with an interval of 0.5 s followed by a 8–12 s pause
before the next paired stimulation.
While P50 gating mostly has been reported as a ratio
measure (S2/S1 or 1- S2/S1 × 100), it has been suggested
that a difference measure might be more reliable [2]. The
latter report suggested the use of the traditional peak
amplitudes for the difference measures. Extending this
idea to the whole waveform, subtraction waveforms also
called difference waves are investigated presently. Differ-
ence waves, where the evoked potential of the same indi-
vidual recorded under one condition is subtracted from a
potential recorded in another condition, have been used
particularly in the research of the Mis Match Negativity
(MMN). The MMN is a negative potential shift evoked
when a deviant stimulus is presented in a series of well-
known stimuli. It is observed even when attention is
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focused on something else than the stimulus series, and
consequently MMN has been conceived as a manifesta-
tion of involuntary attention and as such part of the ori-
enting response [3]. P50 is at a shorter latency than the
MMN but it has been demonstrated that attentional mod-
ulation of the AEP starts at 15 ms post stimulus [4]. In this
sense an abnormal P50 difference wave in schizophrenia
might be an indication of faulty involuntary attentional
Table 1: Amplitudes of mid-latency auditory gating difference wave, P50 gating ratio, sweeps included in the EPs and tobacco 
consumption in schizophrenia spectrum patients (stratified by their negative symptom score) and healthy controls
CON SCH SCH  low SCHhigh
Onset
µV
Fz 0.40** -1.30 -0.68 -1.98
1.41 1.68 1.42 1.77
Cz 1.13** -0.37 0.32 -1.14
1.35 1.14 1.91 2.24
Pz 0.62 -0.12 0.88* -1.25
1.50 2.13 1.26 2.41
Fp1 -0.32* -1.27 -0.59 -2.03
1.30 1.28 0.81 1.31
Fp2 -0.35* -1.37 -0.59* -2.24
1.30 1.44 0.87 1.49
C3' 0.33 -0.17 0.33 -0.74
0.90 1.68 1.32 1.94
C4' 0.57 -0.01 0.46 -0.53
0.99 1.29 1.21 1.25
Peak
µV
Fz 1.31** -0.06 0.85* -1.08
1.64 1.71 0.91 1.87
Cz 1.90* 0.44 1.21 -0.42
1.64 1.58 1.95 2.56
Pz 0.65 -0.30 0.56* -1.28
1.31 1.71 1.19 2.29
Fp1 0.13 -0.41 0.58** -1.52
1.26 1.58 1.04 1.35
Fp2 0.20 -0.40 0.77** -1.71
1.38 1.82 1.27 1.43
C3' 0.76 0.11 0.44 -0.26
1.04 1.26 1.17 1.34
C4' 0.95 0.22 0.76 -0.39
0.82 1.59 1.26 1.78
Other Group Variables
St. P50rat 0.40 0.35 0.35 0.35
0.30 0.22 0.21 0.25
S1Epochs 98** 77 83 71
12 23 18 28
S2Epochs 101** 85 94 76
12 23 16 26
Tobacco 34 75 108 38
47 73 66 63
Mean amplitudes in µV (standard deviation). *) p < 0.05; **) p < 0.01 (post-hoc pairwise comparisons, Bonferroni corrected) when in (CON) 
denoting probability of significant difference between healthy controls (CON, N = 24) and all the schizophrenia spectrum patients (SCH, N = 17), 
when in (SCHlow) denoting probability of significant difference between patients having a negative symptom score (sum of five global SANS (not 
including global attention) items) ranging 0–7 (SCHlow, N = 9) and the patients having scores ranging 8–12 (SCHhigh, N = 8). The P50 ratio (S2/S1 
amplitude) following traditional 10–50 Hz digital filtering has previously been reported [5], where it is compared to two other types of digital 
filtering. Number of included sweeps in the EP in both stimuli (S1 and S2) differs between healthy comparisons subjects and patients, but not within 
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processing at the same time as a small or negative differ-
ence wave could imply a gating defect.
The present data were recorded as part of a larger study
examining gating in un-medicated schizophrenia spec-
trum patients and data on subsamples of the present
patients have been reported previously [5,6]. It is note-
worthy that auditory P50 gating following the standard
processing method [7] and two other comparisons meth-
ods also involving the ratio measure was normal in the
schizophrenic patients included in the present sample [5].
However, when performing the visual peak detection on
the P50 gating data, it was observed that the AEP wave-
form was different in the 30–70 ms latency range in the
patient group, although this was not reflected by the peak
measures. Thus, this is an explorative investigation of
using difference waves on the mid-latency auditory
evoked potential recorded in a P50 gating paradigm and
correlating this to symptom measures.
Methods
Patients (n = 17) were included if they had a diagnosis of
schizophrenia spectrum disorder, age 18 to 50 years, no
current medication and no substance abuse except
tobacco. The controls (n = 24) were physical and mentally
healthy men of ages that matched the patients. All subjects
gave informed consent as approved by the Ethics Com-
mittee and they were paid to participate in the experi-
ment. Only men were included due to large gender
variation on other measures of interest than the present.
DSM-IV diagnoses were established by the Schedules for
Assesment of Neuropsychiatry (SCAN) version 2.1 [8].
The Schedules for Assesment of Positive Symptoms of
Schizophrenia (SAPS) [9] and Schedules for Assesment of
Negative Symptoms of Schizophrenia (SANS) [10] were
performed regarding the last three months. Five patients
had schizotypal personality disorder and twelve patients
were schizophrenic. Psychopathology and other parame-
ters of illness is tabulated in table 1, where the sample is
stratified by their negative symptom score (see below).
Among the patients 12 subjects and among comparison
subjects 9 subjects smoked more than 10 cigarettes a day.
Details of smoking habits are given in table 2.
Recording and stimulus equipment and settings and the
seven electrode montage (Fp1, Fp2, Fz, C3', C4', and Pz +
EOG) were identical to earlier reports from our laboratory
[11]. Auditory stimuli were clicks of 20–10000 Hz, 1.6 ms
duration and 104 dB peSPL delivered binaurally through
earphones. During recording the subjects were seated
comfortably upright with closed eyes in dim light and
with background masking low level (70 dB SPL) white
noise. The subject was enrolled in a fixed schedule of sev-
eral types of EEG experiments and breaks that included
two hourly recording sessions before lunch and one
hourly session after lunch. In each hourly session one run
was recorded of the auditory gating paradigm of 40 paired
click stimuli. Sampling rate was 1 kHz pr channel. Sub-
jects were allowed to smoke in the fixed breaks but not the
last 15 minutes before resuming recording. Sweeps were
rejected if the EOG amplitude exceeded +/- 70 µV, but no
baseline correction was performed. As the low frequency
activity was examined it was considered important to
avoid the de-trending, which would be the consequence
of correcting with a baseline mean measured across a slow
wave. The possible confounding effect of a difference in
baseline was examined by an analysis of variance
(ANOVA), as described below, of the maximum value in
the latency range -5 to +5 ms. No group differences were
observed in baseline or in EOG amplitudes. Following
initial exploration and recent results of selective low pass
filtering [12] the digital frequency band-pass was set at 1–
15 Hz (24 dB/oct roll-off). The difference waveform was
computed by point-to-point subtraction of the S2 wave-
form from the S1 waveform. P50d onset (minimum
amplitude in the latency range 30–50 ms, leading elec-
trode Fz) and P50d peak (max amplitude in the latency
range 40–80 ms, leading electrode Fz) were based on
computerised detection. The difference amplitudes were
analysed using repeated measures analyses of variance
(r.m. ANOVA) in an Electrode*Group matrix. Explora-
Table 2: Illness parameters in the patient group stratified by the 
negative symptom score
SCH low SCHhigh
Positive symptoms 4.0 3.8
2.6 1.8
Disorganized 2.9 2.1
symptoms 2.8 2.4
Negative symptoms 3.9** 10.1
2.6 1.5
Time since medication 76 29
(months) # 88 29
(N = 5) (N = 8)
Total duration of med. 5.2 8.1
treatment (months) 8.8 8.7
Duration of illness 6.7 8.5
(years) 7.9 8.5
Mean values and standard deviations. SCHhigh: N = 8 ; SCHlow: N = 
9, apart from #) "Time since medication", as four patients were drug-
naïve. The SAPS and SANS scores are given within three dimensions 
of schizophrenia psychopathology: Positive (global hallucinations + 
global delusions), disorganised symptomatology (global Formal 
thought disorder + global bizarre behavior + SANS item inappropriate 
affect) and negative (all global scores of the SANS except attention). 
The negative score stratified the sample. "Duration of illness" is 
measured as time since first psychiatric contact. **) p < 0.01. Two of 
the non-psychotic patients were in the SCHhigh group. In the 
SCHhigh group three patients had only received traditional type 
neuroleptics, one had only had modern antipsychotics and one patient 
had tried both types of treatment. In the SCHlow group two patients 
had received traditional type neuroleptics, and six had received 
modern type antipsychotics.Behavioral and Brain Functions 2006, 2:6 http://www.behavioralandbrainfunctions.com/content/2/1/6
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tory, the different parameters of illness as listed in table 1
was entered the analysis as covariates. Only negative
symptoms covaried with P50d onset (F1,15 : 5.413, p =
.03). Consequently, the patient group was stratified by the
median of their negative symptom score. Post-hoc one-
way ANOVA was performed for each channel. One-way
ANOVAs were also performed for the standard P50 gating
measure, previously reported [5], the number of sweeps
included, and the number of cigarettes pr week as listed in
table 2. The reported p-values are Bonferroni corrected for
multiple comparions.
Results
The patients had more negative difference amplitudes
than the controls in P50d onset (main effect of group F 1,39
= 7.925, p = .008) and in P50d peak (main effect of group
F 1,39 = 5.811, p = .02). See figure 1 and table 1. The same
pattern was seen when analysing the S1 P50 onset ampli-
tude (main effect of group F 1,39 = 6.738, p = .01) but only
as a trend in S1 P50 peak (main effect of group F 1,39 =
3.314, p = .08). No group differences were seen at the S2
amplitudes. The most negative amplitudes were seen in
the patients having high ratings on the SANS (P50d onset:
F 1,15 = 6.290, p = .02; P50d peak: F 1,15 = 10.081, p = .006).
The AEPs were derived from more epochs in the healthy
comparison group than the patient group, but no differ-
ence was observed between the patient subgroups, see
table 2.
Discussion
The patients had a negative difference amplitude in the
30–70 ms latency range frontally, while the healthy con-
trols had a positive P50 difference component, a finding
that is in agreement with most previous studies of P50 gat-
ing in schizophrenia based on 10–50 Hz filtered data and
the ratio measure [7,13]. The major group difference of
the P50d onset amplitude was also seen in the S1 ampli-
tude but not in the S2 amplitude. This finding is in agree-
ment with a study by [12], in which the low frequency P50
S1 amplitude was the group discriminating factor.
The patients having high negative symptom scores had a
particular augmentation of negative amplitude at the pre-
frontal channels, corresponding to a lack of positive
deflection in S1 at vertex. The possibility of contamina-
tion by reflex eye movements in S1 is contradicted by the
lack of correlation to the number of rejected sweeps. Con-
tamination by volume conduction from the frontalis mus-
cle EMG would mostly be filtered out by the frequency
band selected, but it cannot be ruled out [14]. Then the
findings would have to be interpreted as increased reflex
activity with increasing negative symptoms an effect
which could be related to an orienting response or a slight
startle reflex. The orienting response has been extensively
investigated in schizophrenia by way of the skin conduct-
ance response reviewed in [15-17]. Increased negative
symptoms are associated with decreased orienting
response and this is not in accordance with the findings
here [18]. Startle habituation is decreased in schizo-
phrenic patients, but it is not correlated to negative symp-
toms [19]. Recording of P50 gating and simultaneous
facial muscle activity in schizophrenic patients would be
necessary to solve the issue.
Measuring P50 gating as ratio, one of the earlier reports
showed no difference in gating between schizophrenic
patients low and high in negative symptoms [20]. Later
studies have mostly supported this. Light and colleagues
[21] reported that negative symptoms only accounted for
2% of the variance in gating and a recent meta-analysis
showed that symptoms do not predict P50 gating,
although this might be due to insuffient statistical power
[22]. In opposition to this but in agreement with the
present low frequency difference analysis of P50 data, Rin-
Grand average of stimulus one, stimulus two and difference  wave at the central frontal channel in the two groups Figure 1
Grand average of stimulus one, stimulus two and dif-
ference wave at the central frontal channel in the 
two groups. The grand average auditory evoked potentials 
at the frontal channel (Fz) in the control group (black line, N 
= 24) and the schizophrenia spectrum patients (red line, N = 
17). From top the stimulus one (S1) waveform, the stimulus 
two (S2) waveform, and the difference wave (S1–S2) in the 
groups. At bottom the difference wave of the electro-oculo-
gram (EOGd) Arrowhead points at P50d.Behavioral and Brain Functions 2006, 2:6 http://www.behavioralandbrainfunctions.com/content/2/1/6
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gel and colleagues found a positive correlation between
the negative symptom subscale of the Positive and Nega-
tive Syndrome Scale for Schizophrenia (PANSS) and gat-
ing deficits [23]. The negative items on SANS and PANSS
have highly significant correlations [24]. Furthermore,
Yee and colleagues [13] found that anergia and atten-
tional impairment correlated with the gating deficiency.
In the present data the ratio measure of P50 gating did not
show any difference between the two groups nor between
patient subgroups [5]. This could imply that the low fre-
quency filtering unveil differences between patient sub-
groups particularly on S1 in accordance with several
studies where the main difference in gating has been
explained by variations in the S1 amplitude [25-29].
The P50 paradigm was at first reported to only track so-
called "automatic" or pre-attentive processing
[1,26,30,31]. Nonetheless, later studies of P50 [32,33]
showed a direct effect of task allocation on the S1 and S2
amplitudes. Amplitude increase was seen when a discrim-
ination task was on either S1 [31,7] or S2 [31,32,34].
When subjects were distracted during recording S1 ampli-
tude was attenuated and S2 amplitude constant [31,7]. It
seems possible that the low frequency S1 P50 amplitude
tracks an aspect of involuntary attention, which are
delayed and diminished in schizophrenic patients. Sev-
eral theories concerning the basic deficits in schizophre-
nia exist. Among them, a hypothesized weakening of the
effect of regularity on stimulus processing [[35], [36],
[37]] i.e. a decrease in expectancy during repeated stimu-
lation seems to fit the present finding of low S1 amplitude
best.
In conclusion, un-medicated male schizophrenia spec-
trum patients show an attenuation of low frequency
amplitude at the first stimulus of the P50-gating para-
digm. This is likely to reflect an abnormality in readiness
and not an abnormality in gating.
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